About Hair4U Spray and Solution 2% Glenmark Pharmaceuticals Ltd.
Hair4U Spray and Solution 2% is a minoxidil-based topical formulation manufactured by Glenmark Pharmaceuticals Ltd. Minoxidil is a potent vasodilator compound originally developed for cardiovascular research applications. This pharmaceutical-grade preparation provides researchers with a standardised 2% concentration for investigating minoxidil’s effects on vascular smooth muscle relaxation and potassium channel activation in laboratory settings. The compound demonstrates significant research value in studying peripheral vasodilation mechanisms and microcirculatory effects. At Stroid UK Shop, we supply authentic Glenmark formulations to support advanced cardiovascular research protocols.
Laboratory Research Applications
Researchers utilise Hair4U 2% minoxidil solution to study vasodilatory pathways through ATP-sensitive potassium channel activation. The compound enables investigation of smooth muscle hyperpolarisation mechanisms and nitric oxide-independent vasodilation processes. Laboratory studies examine minoxidil’s effects on arteriolar resistance and microvascular blood flow dynamics in ex-vivo tissue preparations. Scientists analyse the compound’s prostaglandin E2 synthesis modulation and its role in follicular dermal papilla cell metabolism. Our cardiovascular research compounds complement studies alongside established research molecules like those found in our SARMs collection and peptide research range. The topical formulation allows precise dosimetric control for concentration-response studies and pharmacokinetic absorption research.
Product Specifications
| Active Ingredient | Minoxidil 2% |
|---|---|
| Manufacturer | Glenmark Pharmaceuticals Ltd |
| CAS Number | 38304-91-5 |
| Molecular Formula | C₉H₁₅N₅O |
| Molecular Weight | 209.25 g/mol |
| Form | Topical spray/solution |
| Storage | Room temperature, dry conditions |
| Research Use | In-vitro laboratory studies only |
Research Compliance Statement
Hair4U Spray and Solution 2% minoxidil is supplied exclusively for in-vitro laboratory research purposes. This pharmaceutical preparation is not intended for human consumption, therapeutic use, or clinical application. Researchers must maintain appropriate laboratory safety protocols when handling this vasodilator compound. The product should be stored according to manufacturer specifications and used only by qualified laboratory personnel conducting approved research studies. All experimental procedures must comply with institutional research guidelines and regulatory requirements for chemical research compounds.
